BIOMAT Database Logo BIOMAT Database Logo

[Prenatal prognosis of the hemolytic disease of the newborn]. 1972

K Polácek, and A Zwinger, and B Vedra

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D004899 Erythroblastosis, Fetal A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN. Hemolytic Disease of Newborn,Erythroblastosis Fetalis,Erythroblastoses, Fetal,Erythroblastosis Fetali,Fetal Erythroblastoses,Fetal Erythroblastosis,Fetali, Erythroblastosis,Fetalis, Erythroblastosis,Newborn Hemolytic Disease,Newborn Hemolytic Diseases
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000653 Amniotic Fluid A clear, yellowish liquid that envelopes the FETUS inside the sac of AMNION. In the first trimester, it is likely a transudate of maternal or fetal plasma. In the second trimester, amniotic fluid derives primarily from fetal lung and kidney. Cells or substances in this fluid can be removed for prenatal diagnostic tests (AMNIOCENTESIS). Amniotic Fluid Index,Amniotic Fluid Indices,Amniotic Fluids,Fluid Index, Amniotic,Fluid Indices, Amniotic,Fluid, Amniotic,Fluids, Amniotic,Index, Amniotic Fluid,Indices, Amniotic Fluid
D001663 Bilirubin A bile pigment that is a degradation product of HEME. Bilirubin IX alpha,Bilirubin, (15E)-Isomer,Bilirubin, (4E)-Isomer,Bilirubin, (4E,15E)-Isomer,Bilirubin, Calcium Salt,Bilirubin, Disodium Salt,Bilirubin, Monosodium Salt,Calcium Bilirubinate,Hematoidin,delta-Bilirubin,Bilirubinate, Calcium,Calcium Salt Bilirubin,Disodium Salt Bilirubin,Monosodium Salt Bilirubin,Salt Bilirubin, Calcium,delta Bilirubin
D012204 Rh-Hr Blood-Group System Erythrocyte isoantigens of the Rh (Rhesus) blood group system, the most complex of all human blood groups. The major antigen Rh or D is the most common cause of erythroblastosis fetalis. Rh Factors,Rhesus Blood-Group System,Antigen D, Rh Blood Group,Blood-Group System, Rh-Hr,Blood-Group System, Rhesus,Blood-Group Systems, Rh-Hr,Blood-Group Systems, Rhesus,Factor, Rh,Factors, Rh,Rh Factor,Rh Hr Blood Group System,Rh-Hr Blood-Group Systems,Rhesus Blood Group System,Rhesus Blood-Group Systems,System, Rh-Hr Blood-Group,System, Rhesus Blood-Group,Systems, Rh-Hr Blood-Group,Systems, Rhesus Blood-Group

Related Publications

K Polácek, and A Zwinger, and B Vedra
[Prenatal prognosis of hemolytic disease of the newborn. 1. Clinical importance].
September 1960, Ceskoslovenska gynekologie,
K Polácek, and A Zwinger, and B Vedra
[Prenatal prognosis of hemolytic disease of newborn. II. Prognosits value of maternal antibodies].
April 1961, Ceskoslovenska gynekologie,
K Polácek, and A Zwinger, and B Vedra
Factors in prenatal prognosis of hemolytic disease of the newborn due to Rh immunization.
November 1966, American journal of obstetrics and gynecology,
K Polácek, and A Zwinger, and B Vedra
[Prenatal prevention of hemolytic disease of the newborn].
September 1960, Minerva ginecologica,
K Polácek, and A Zwinger, and B Vedra
[The prenatal prophylaxis of hemolytic disease of the newborn].
December 1960, Minerva medica,
K Polácek, and A Zwinger, and B Vedra
[Prenatal immunological research on hemolytic disease of the newborn].
January 1980, Archivio per le scienze mediche,
K Polácek, and A Zwinger, and B Vedra
[Hemolytic disease of the newborn. Prenatal diagnosis, prognosis and intrauterine transfusion in the severely diseased fetus].
March 1969, Medizinische Klinik,
K Polácek, and A Zwinger, and B Vedra
[Prenatal prognosis of hemolytic disease in newborn infants. IV. Familial differences in the development of isoimmunization].
December 1965, Ceskoslovenska gynekologie,
K Polácek, and A Zwinger, and B Vedra
On the prenatal treatment of hemolytic disease of the newborn.
January 1948, Archivio italiano di pediatria e puericoltura,
K Polácek, and A Zwinger, and B Vedra
[Prenatal diagnosis and therapy of hemolytic disease of the newborn].
March 1985, Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde,
Copied contents to your clipboard!